|Life Science De
||ORD NPV (DI)
||EPS - Basic
||Market Cap (m)
|Life Science De Daily Update: Life Science De is listed in the Mining sector of the London Stock Exchange with ticker LIFE. The last closing price for Life Science De was 2.38p.|
Life Science De has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 37,501,033 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Life Science De is £890,649.53.
|mikeh30: FFWD raised well below their share price when they did it|
|the stigologist: Because slow steady share price development is what long term shareholders want
Good move by Management
Too many pump and dump merchants detract from quality of the shareholder base|
|the stigologist: Incredibly shoddy from the Company and the NOMAD on so many levels
4 December 2015
Life Science Developments Limited
("LIFE" or "the Company")
LIFE Moves to Correct Financial Website Identification of Company
On 5 October 2015, the Company sold its copper project, changed its name and became a life science and biotech investment company; it also appointed Jim Mellon as a non-executive director. Since then, however, some online share quote services have continued to identify LIFE by his old name ("Copper Development Corporation") and have continued to describe the Company as a copper project developer. As a result, one online financial publication issued in recent days reports that incorrectly tied LIFE's share price movements and corporate prospects implicitly to that of the copper mining sector.
Life Science Developments Limited (AIM: LIFE) has now contacted several online share quote services and financial publications to ask them to update their records on LIFE, and have provided the with the correct information, which was in the Company's news announcement on 5 October 2015. The company will monitor this on the Internet to make sure that financial websites provide the correct corporate name and corporate description.
Mitch Alland, Executive Chairman of LIFE, commented:
We are working together with Jim Mellon to embark on our path of biotech investments. Jim has not only been highly successful in pioneering ventures in biotech and life sciences, but is also well known as a knowledgeable and effective entrepreneur and as an author of widely read books on investment.|
Life Science De share price data is direct from the London Stock Exchange